Sjogren's syndrome

被引:5
|
作者
Balint, Geza [1 ]
Buchanan, W. Watson [2 ]
Kean, Colin A. [3 ]
Kean, Walter [2 ,3 ]
Rainsford, K. D. [4 ]
机构
[1] Natl Inst Rheumatism & Physiotherapy, Dept Rheumatol 3, Frankel Leo ut 27-29, H-1023 Budapest, Hungary
[2] McMaster Univ, Dept Med, Hamilton, ON L8P 1H6, Canada
[3] Haldimand War Mem Hosp, 400 Broad St, Dunnville, ON N1A 2P7, Canada
[4] Sheffield Hallam Univ, Sheffield S1 1WB, England
关键词
Keratoconjunctivitis sicca; Dry eyes; Xerostomia; Dry mouth; Salivary gland enlargement; Connective tissue disease; VITAMIN-D; LYMPHOMA; EXPRESSION; CRITERIA; DISEASE; TESTS;
D O I
10.1007/s10787-023-01222-z
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sjogren's syndrome (SS) is characterised as keratoconjunctivitis sicca (dry eyes), xerostomia (dry mouth) commonly associated with salivary gland enlargement, and is referred to as Primary Sjogren's syndrome. It is known as Secondary Sjogren's syndrome when it occurs in patients, with connective tissue disease, such as rheumatoid arthritis, systemic lupus erythematosus, polyarthritis nodosa, polymyositis, and systemic sclerosis. SS has also been associated with chronic graft-versus-host disease after allogeneic bone marrow transplantation, human immunodeficiency syndrome (AIDS), hepatitis C infection (HCV), chronic biliary cirrhosis, neoplastic and myeloplastic syndromes, fibromyalgia, and chronic fatigue syndrome.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 50 条
  • [31] Contribution of Genetic Factors to Sjogren's Syndrome and Sjogren's Syndrome Related Lymphomagenesis
    Nezos, Adrianos
    Mavragani, Clio P.
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [32] Ianalumab for Sjogren's syndrome
    Thorley, Jennifer
    [J]. LANCET RHEUMATOLOGY, 2022, 4 (01): : E20 - E20
  • [33] Remibrutinib for Sjogren's syndrome
    Thorley, Jennifer
    [J]. LANCET RHEUMATOLOGY, 2024, 6 (01): : e9 - e9
  • [34] Sjogren's syndrome in present
    Feltsan, T.
    Stanko, P.
    Mracna, J.
    [J]. BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2012, 113 (08): : 514 - 516
  • [35] Sjogren's syndrome: pathogenesis
    Tabbara, K
    Sharara, N
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 1999, 9 (01) : 1 - 7
  • [36] Biologics in Sjogren's syndrome
    Skarlis, Charalampos
    Marketos, Nikolaos
    Mavragani, Clio P.
    [J]. PHARMACOLOGICAL RESEARCH, 2019, 147
  • [37] Primary Sjogren's Syndrome
    Mariette, Xavier
    Criswell, Lindsey A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (10): : 931 - 939
  • [38] LYMPHADENOPATHY IN SJOGREN'S SYNDROME
    Chatzis, L.
    Pezoulas, V. C.
    Stergiou, I. E.
    Paraskevi, V
    Baldini, C.
    Exarchos, T. P.
    Fotiadis, D., I
    Skopouli, F.
    Goules, A., V
    Voulgarelis, M.
    Moutsopoulos, H. M.
    Tzioufas, A. G.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (12) : 46 - 47
  • [39] Sjogren's syndrome and mimickers
    Tzioufas, Athanasios G.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 728 - 728
  • [40] Sjogren's syndrome: Terminology
    Oxholm, P
    Asmussen, K
    Axell, T
    VanBijsterveld, OP
    Jacobsson, L
    Konttinen, Y
    Manthorpe, R
    Nederfors, T
    Prause, JU
    Schiodt, M
    Thorn, JJ
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1995, 13 (06) : 693 - 696